Results of the phase III Inter-B-NHL-ritux 2010 clinical trial shows the effectiveness of Rituximab in improving the survival rate among kids with non-Hogkin lymphoma.
from Medindia Health News https://ift.tt/3gUhhY4
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
June 05, 2020
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.